Experimental confirmation of new drug-target interactions predicted by drug profile matching

László Végner, Ágnes Peragovics, László Tombor, Balázs Jelinek, P. Czobor, Andreas Bender, Zoltán Simon, A. Málnási-Csizmadia

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

We recently introduced Drug Profile Matching (DPM), a novel affinity fingerprinting-based in silico drug repositioning approach. DPM is able to quantitatively predict the complete effect profiles of compounds via probability scores. In the present work, in order to investigate the predictive power of DPM, three effect categories, namely, angiotensin-converting enzyme inhibitor, cyclooxygenase inhibitor, and dopamine agent, were selected and predictions were verified by literature analysis as well as experimentally. A total of 72% of the newly predicted and tested dopaminergic compounds were confirmed by tests on D1 and D2 expressing cell cultures. 33% and 23% of the ACE and COX inhibitory predictions were confirmed by in vitro tests, respectively. Dose-dependent inhibition curves were measured for seven drugs, and their inhibitory constants (Ki) were determined. Our study overall demonstrates that DPM is an effective approach to reveal novel drug-target pairs that may result in repositioning these drugs.

Original languageEnglish
Pages (from-to)8377-8388
Number of pages12
JournalJournal of Medicinal Chemistry
Volume56
Issue number21
DOIs
Publication statusPublished - Nov 14 2013

Fingerprint

Drug Interactions
Drug Repositioning
Pharmaceutical Preparations
Dopamine Agents
Cyclooxygenase Inhibitors
Angiotensin-Converting Enzyme Inhibitors
Computer Simulation
Cell Culture Techniques

ASJC Scopus subject areas

  • Molecular Medicine
  • Drug Discovery

Cite this

Experimental confirmation of new drug-target interactions predicted by drug profile matching. / Végner, László; Peragovics, Ágnes; Tombor, László; Jelinek, Balázs; Czobor, P.; Bender, Andreas; Simon, Zoltán; Málnási-Csizmadia, A.

In: Journal of Medicinal Chemistry, Vol. 56, No. 21, 14.11.2013, p. 8377-8388.

Research output: Contribution to journalArticle

Végner, László ; Peragovics, Ágnes ; Tombor, László ; Jelinek, Balázs ; Czobor, P. ; Bender, Andreas ; Simon, Zoltán ; Málnási-Csizmadia, A. / Experimental confirmation of new drug-target interactions predicted by drug profile matching. In: Journal of Medicinal Chemistry. 2013 ; Vol. 56, No. 21. pp. 8377-8388.
@article{5fa2ce0968534a239a1ab24e971f978b,
title = "Experimental confirmation of new drug-target interactions predicted by drug profile matching",
abstract = "We recently introduced Drug Profile Matching (DPM), a novel affinity fingerprinting-based in silico drug repositioning approach. DPM is able to quantitatively predict the complete effect profiles of compounds via probability scores. In the present work, in order to investigate the predictive power of DPM, three effect categories, namely, angiotensin-converting enzyme inhibitor, cyclooxygenase inhibitor, and dopamine agent, were selected and predictions were verified by literature analysis as well as experimentally. A total of 72{\%} of the newly predicted and tested dopaminergic compounds were confirmed by tests on D1 and D2 expressing cell cultures. 33{\%} and 23{\%} of the ACE and COX inhibitory predictions were confirmed by in vitro tests, respectively. Dose-dependent inhibition curves were measured for seven drugs, and their inhibitory constants (Ki) were determined. Our study overall demonstrates that DPM is an effective approach to reveal novel drug-target pairs that may result in repositioning these drugs.",
author = "L{\'a}szl{\'o} V{\'e}gner and {\'A}gnes Peragovics and L{\'a}szl{\'o} Tombor and Bal{\'a}zs Jelinek and P. Czobor and Andreas Bender and Zolt{\'a}n Simon and A. M{\'a}ln{\'a}si-Csizmadia",
year = "2013",
month = "11",
day = "14",
doi = "10.1021/jm400813y",
language = "English",
volume = "56",
pages = "8377--8388",
journal = "Journal of Medicinal Chemistry",
issn = "0022-2623",
publisher = "American Chemical Society",
number = "21",

}

TY - JOUR

T1 - Experimental confirmation of new drug-target interactions predicted by drug profile matching

AU - Végner, László

AU - Peragovics, Ágnes

AU - Tombor, László

AU - Jelinek, Balázs

AU - Czobor, P.

AU - Bender, Andreas

AU - Simon, Zoltán

AU - Málnási-Csizmadia, A.

PY - 2013/11/14

Y1 - 2013/11/14

N2 - We recently introduced Drug Profile Matching (DPM), a novel affinity fingerprinting-based in silico drug repositioning approach. DPM is able to quantitatively predict the complete effect profiles of compounds via probability scores. In the present work, in order to investigate the predictive power of DPM, three effect categories, namely, angiotensin-converting enzyme inhibitor, cyclooxygenase inhibitor, and dopamine agent, were selected and predictions were verified by literature analysis as well as experimentally. A total of 72% of the newly predicted and tested dopaminergic compounds were confirmed by tests on D1 and D2 expressing cell cultures. 33% and 23% of the ACE and COX inhibitory predictions were confirmed by in vitro tests, respectively. Dose-dependent inhibition curves were measured for seven drugs, and their inhibitory constants (Ki) were determined. Our study overall demonstrates that DPM is an effective approach to reveal novel drug-target pairs that may result in repositioning these drugs.

AB - We recently introduced Drug Profile Matching (DPM), a novel affinity fingerprinting-based in silico drug repositioning approach. DPM is able to quantitatively predict the complete effect profiles of compounds via probability scores. In the present work, in order to investigate the predictive power of DPM, three effect categories, namely, angiotensin-converting enzyme inhibitor, cyclooxygenase inhibitor, and dopamine agent, were selected and predictions were verified by literature analysis as well as experimentally. A total of 72% of the newly predicted and tested dopaminergic compounds were confirmed by tests on D1 and D2 expressing cell cultures. 33% and 23% of the ACE and COX inhibitory predictions were confirmed by in vitro tests, respectively. Dose-dependent inhibition curves were measured for seven drugs, and their inhibitory constants (Ki) were determined. Our study overall demonstrates that DPM is an effective approach to reveal novel drug-target pairs that may result in repositioning these drugs.

UR - http://www.scopus.com/inward/record.url?scp=84887978605&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84887978605&partnerID=8YFLogxK

U2 - 10.1021/jm400813y

DO - 10.1021/jm400813y

M3 - Article

C2 - 24088053

AN - SCOPUS:84887978605

VL - 56

SP - 8377

EP - 8388

JO - Journal of Medicinal Chemistry

JF - Journal of Medicinal Chemistry

SN - 0022-2623

IS - 21

ER -